Antitrust experts debate regulation to stop expensive drugs
Despite higher drug prices in the US than in other nations, some antitrust observers doubt that government intervention is the answer to this problem.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10